PATENT CLAIM ANALYSIS

Application Number: 15763095
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "171000"]

Abstract:
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):

Claim (Index 2):
The compound of  claim 1 , E is selected from aryl, heteroaryl, carbocyclyl, heterocyclyl, any of which is optionally substituted with one to three R 5  substituents.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13805471', '13780557', '15530681', '14376307', '15410716']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8232473319746196
- 35 USC 102 Novelty (BERT): 0.5419753482942345
- Combined Prediction Score: 0.7951201336065812
- Mean Citation Score: 394.870806
- Max Citation Score: 395.57306
- Similarity Product: 291.22639413816927

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test